Tennessee Companies Support American Cancer Society’s Cancer Prevention Study-3
In 2011 alone, nearly 1.6 million people in the United States are expected to be diagnosed with cancer and more than 570,000 will die of the disease. The American Cancer Society is dedicated to its mission of saving lives and diminishing the suffering from cancer, and the latest opportunity to pave the way for the next generation of cancer is through the recent research study, CPS-3.
To better understand ways to prevent cancer, the American Cancer Society has embarked on a nationwide research study, the Cancer Prevention Study-3 (CPS-3). This study is expected to help better understand the genetic, environmental and lifestyle factors that cause or prevent cancer in hopes to ultimately eliminate cancer as a major health concern.
Researchers will use the data from CPS-3 to build on evidence from a series of American Cancer Society studies that began in the 1950s and involved hundreds of thousands of volunteer participants. The Hammond-Horn Study and previous Cancer Prevention Studies (CPS-I, and CPS-II) have played a major role in understanding cancer prevention and risk, and have contributed significantly to the scientific literature and to the development of public health guidelines and recommendations. Those studies confirmed the link between cigarette smoking and lung cancer, showed that obesity increases the risk of several cancers, and linked aspirin use to a lower death rate from colon cancer. The current study, CPS-II, began in 1982 and is still ongoing. But changes in lifestyle and in the understanding of cancer in the more than two decades since its launch make it important to begin a new cohort.
“Our previous cancer prevention studies have been instrumental in helping us identify some of the major factors that can affect cancer risk,” said Alpa V. Patel, Ph.D., principal investigator of CPS-3. “CPS-3 holds the best hope of identifying new and emerging cancer risks, and we can only do this if members of the community are willing to become involved.”
Currently, the CPS-3 study is gathering participants nationwide between the ages of 30-65, have never been diagnosed with cancer and pledge to be a part of the study for the next 20-30 years. Study enrollment opportunities continue to take place at various venues in select communities across the United States and Puerto Rico. Corporations across the nation have opened their doors as CPS-3 enrollment sites for their employees. There are plans for Tennessee corporations to participate as CPS-3 enrollment sites in the upcoming year.
“Many individuals diagnosed with cancer struggle to answer the question, ‘What caused my cancer?’ In many cases, we don’t know the answer,” said Dr. Patel. “CPS-3 will help us better understand what factors cause cancer, and once we know that, we can be better equipped to prevent cancer.”